Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: The results of clinical and parasitological examinations 11 years post-treatment

Annals of Tropical Medicine and Parasitology

Volumn 99, Issue 8, 2005, Pages 733-741

  Apt, W ^a   Arribada, A ^b,c   Zulantay, I ^a   Solari, A ^a   Sanchez G ^a   Mundaca, K ^a   Coronado, X ^a   Rodriguez J ^a   Gil, L C ^d   Osuna, A ^e  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c Hospital Exequiel González Cortés   (Chile)

^d HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^e UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ITRACONAZOLE; PARASITE ANTIBODY; PROTOZOAL DNA; TRYPANOSOMA CRUZI ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DNA DETERMINATION; DRUG CHOICE; DRUG EFFICACY; ELECTROCARDIOGRAM; FECES ANALYSIS; FOLLOW UP; HEART ARRHYTHMIA; HEART BLOCK; HEART DISEASE; HUMAN; HYBRIDIZATION; MAJOR CLINICAL STUDY; PARASITOLOGY; POLYMERASE CHAIN REACTION; SIDE EFFECT; TREATMENT OUTCOME; TRIATOMA INFESTANS; TRYPANOSOMA CRUZI; XENODIAGNOSIS;

MASTIGOPHORA (FLAGELLATES); TRIATOMA INFESTANS; TRYPANOSOMA CRUZI;

EID: 28144459142     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485905X75403     Document Type: Article

References (32)

1. Ahmed, R. & Gray, D. (1996). Immunological memory and protective immunity: understanding their relation. Science, 272, 54-60.
2. Andrade, A., Zicker, F., Oliveira, R., Silva, S., Luquetti, A., Travassos, L., Almeida, I., Andrade, S., Andrade, J. & Martelli, C. (1996). Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet, 348, 1407-1413.
3. Andrade, S., Pimentel, A., de Souza, M. & Andrade, Z. (2000). Instersticial dendritic cells of the heart harbor Trypanosoma cruzi antigens in experimentally infected dogs: importance for the pathogenesis of chagasic myocarditis. American Journal of Tropical Medicine and Hygiene, 63, 64-70.
4. Apt, W., Aguilera, X., Arribada, A., Gómez, L., Miles, M. & Widmer, G. (1987). Epidemiology of Chagas disease in northern Chile: isoenzyme profile of Trypanosoma cruzi from domestic and silvatic transmission cycles and their associations with cardiopathy. American Journal of Tropical Medicine and Hygiene, 37, 302-307.
5. Apt, W., Aguilera, X., Arribada, A., Pérez, C., Miranda, C., Sánchez, G., Zulantay, I., Cortés, P., Rodríguez, J. & Juri, D. (1998). Treatment of chronic Chagas disease with itraconazole and allopurinol. American Journal of Tropical Medicine and Hygiene, 59, 133-138.
6. Apt, W., Arribada, A., Zulantay, I., Sánchez, G., Vargas, L. & Rodriguez, J. (2003). Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up. Annals of Tropical Medicine and Parasitology, 97, 23-29.
7. Arribada, A., Apt, W. & Ugarte, J. (1986). A four year follow up surveys of chagasic cardiopathy in Chile. Bulletin of the Pan American Health Organization, 20, 254-266.
8. Basquiera, A., Sembaj, A., Aguerri, A., Omelianiuk, M., Guzmán, S., Moreno-Barral, J., Caeiro, T., Madoery, R. & Salomone, O. (2003). Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart, 89, 1186-1190.
9. Cançado, C. (1999). Criteria of Chagas disease cure. Memórias do Instituto Oswaldo Cruz, 94, 331-336.
10. Cerisola, J. (1969). Evolución serológica de pacientes con enfermedad de Chagas aguda tratados con Bay 2502. Boletín Chileno de Parasitología, 24, 54-59.
11. De Souza, W. (2002). From the cell biology to the development of new chemotherapeutic approaches against trypanosomatids: dreams and reality. Kinetoplastid Biology and Disease, 1, 1-21
12. Gallerano, R., Marr, J. & Soza, R. (1990). Therapeutic efficacy of allopurinol in patients with chronic Chagas disesase. American Journal of Tropical Medicine and Hygiene, 43, 159-166.
13. Garzonni, L., Caldera, A., Meirelles, M., de Castro, S., Docampo, R., Meints, G., Oldfield, E. & Urbina, J. (2004). Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. International Journal of Antimicrobial Agents, 23, 273-285.
14. Gazzinelli, R., Galvao, L., Krautz, G., Lima, A., Cancado, R., Sharfstein, J. & Krettli, A. (1993). Use of Trypanosoma cruzi purified glycoprotein (GP 57/51) or trypomastigote-shed antigens to assess cure for human Chagas disease. American Journal of Tropical Medicine and Hygiene, 49, 625-635.
15. Marr, J. J. (1991). Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. Journal of Laboratory and Clinical Medicine, 118, 111-119.
16. McCabe, E., Remington, J. & Araujo, F. (1986). In vitro and in vivo effect of itraconazole against Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene, 35, 280-284.
17. Moreira, A., de Souza, H., Amato Neto, V., Matsubara, L., Pinto, L., Tolezano, J., Nunes, E. & Okomura, M. (1992). Avaliaçao da atividad terapeutica do itraconazole nas infecçoes cronicas, experimental e humana, pelo Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo, 34, 177-180.
18. Ornelas Toledo, M., Bahia, M., Carneiro, C., Martins-Filho, O., Tibayrenc, M., Barnabe, C., Tafuri, W. & Lana, M. (2003). Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrobial Agents and Chemotherapy, 47, 223-230.
19. a Reunion de la Comisión Intergubernamental del Cono Sur para la Eliminación de Triatoma infestans y la Interrupción de la Transmisión Transfusional de la Tripanosomiasis Americana (INCOSUR/Chagas), pp. 129-134. Washington, DC: Pan American Health Organization.
20. Prata, A. (2001). Clinical and epidemiological aspects of Chagas disease. Lancet Infectious Diseases, 1, 92-100.
21. Rodrigues Coura, J. & de Castro, S. (2002). A critical review on Chagas disease chemotherapy. Memórias do Instituto Oswaldo Cruz, 97, 3-24.
22. Schenone, H., Alfaro, E. & Rojas, A. (1974). Bases y rendimiento del xenodiagnóstico en la infección humana. Boletín Chileno de Parasitología, 29, 24-26
23. Solari, A., Ortiz, S., Soto, A., Arancibia, C., Campillay, R., Contreras, P., Salinas, A., Rojas, A. & Schenone, H. (2001). Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR. Journal of Antimicrobiological Chemotherapy, 48, 151-519.
24. Sosa Stani, S., Segura, E., Ruiz, A., Velásquez, E., Porcel, B. & Yampotis, C. (1998). Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas disease. American Journal of Tropical Medicine and Hygiene, 59, 526-529
25. Tomomori-Yamashita, J., Deps, P., Almeida, D., Enokihara, M., de Seixas, M. & Freymuller, E. (1997). Cutaneous manifestations of Chagas disease after heart transplantation: succesful treatment with allopurinol. British Journal of Dermatology, 37, 626-630.
26. Urbina, J. & Docampo, R. (2003). Specific chemotherapy of Chagas disease: controversies and advances. Trends in Parasitology, 19, 495-501.
27. Urbina, J., Concepción, J., Caldera, A., Payares, G., Sanoja, C., Otomo, T. & Hiyoshi, H. (2004). In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy, 48, 2379-2387.
28. Viotti, E., Vigliano, C., Armenti, H. & Segura, E. (1994). Treatment of chronic chagasic disease with benznidazole: clinical and serological evolution of patients with long-term follow-up. American Heart Journal, 127, 151-162.
29. Wincker, P., Bosseno, N. F., Britto, C., Yaksic, N., Cardoso, M., Morel, C. & Breniere, S. (1994). High correlation between Chagas' disease serology and PCR-based detection of Trypanosoma cruzi kinetoplast DNA in Bolivian children living in a edemic area. FEMS Microbiology Letters, 124, 419-424.
30. World Health Organization (2000). Chagas disease interrupted in Chile. TDR News, 61, 10.
31. World Health Organization (2002). Control of Chagas disease. Technical Reports Series No. 905. Geneva: WHO.
32. Zulantay, I., Honores, P., Solari, A., Apt, W., Ortiz, S., Osuna, A., Rojas, A., Lopez, B. & Sánchez, G. (2004). Use of polymerase chain reaction (PCR) and hybridizations assays to detect Trypanosoma cruzi in chronic chagasic patientes treated with itraconazole or allopurinol. Diagnostic Microbiology and Infectious Disease, 48, 253-257.